This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chandrashekhar, Y. Articles by Anand, I. Search for Related Content PubMed PubMed Citation Articles by Chandrashekhar, Y. Articles by Anand, I.

BASIC SCIENCE

Long-Term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction

^* Division of Cardiology, VA Medical Center and University of Minnesota, Minneapolis, Minnesota, USA

Manuscript received June 19, 2003; revised manuscript received September 15, 2003, accepted September 15, 2003.

^* Reprint requests and correspondence: Dr. Y. Chandrashekhar, Associate Professor of Medicine, University of Minnesota, Division of Cardiology IIIc, VAMC, 1 Veterans Drive, Minneapolis, Minnesota 55417, USA.
shekh003{at}tc.umn.edu

OBJECTIVES: This study was designed to evaluate whether in vivo caspase inhibition can prevent myocardial contractile protein degradation, improve myocardial function, and attenuate ventricular remodeling.

BACKGROUND: Apoptosis is thought to play an important role in the development and progression of heart failure (HF) after a myocardial infarction (MI). However, it is not known whether inhibiting apoptosis can attenuate left ventricular (LV) remodeling and minimize systolic dysfunction.

METHODS: A 28-day infusion of caspase inhibitor (n = 12) or vehicle (n = 9) was administered to rats immediately after an anterior MI. In addition, five sham-operated rats given the caspase inhibitor were compared with 17 untreated sham-operated animals to study effects in non-MI rats. Left ventricular function, remodeling parameters, and hemodynamics were studied four weeks later. Myocardial caspase 3 activation and troponin-I contractile protein cleavage were studied in the non-infarct, remote LV myocardium using Western blots. Apoptosis was assessed using immunohistochemistry for activated caspase-positive cells as well as the TUNEL method. Collagen volume was estimated using morphometry.

RESULTS: Caspase inhibition reduced myocardial caspase 3 activation. This was accompanied by less cleavage of troponin-I, an important component of the cardiac contractile apparatus, and fewer apoptotic cardiomyocytes. Furthermore, caspase inhibition reduced LV-weight-to-body-weight ratio, decreased myocardial interstitial collagen deposition, attenuated LV remodeling, and better preserved LV systolic function after MI.

CONCLUSIONS: Caspase inhibition, started soon after MI and continued for four weeks, preserves myocardial contractile proteins, reduces systolic dysfunction, and attenuates ventricular remodeling. These findings may have important therapeutic implications in post-MI HF.

Abbreviations and Acronyms   ANOVA = analysis of variance   DMSO = dimethyl sulfoxide   HF = heart failure   LV = left ventricle/ventricular   MI = myocardial infarction

This article has been cited by other articles:

				G. W. Dorn II Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling Cardiovasc Res, February 15, 2009; 81(3): 465 - 473. [Abstract] [Full Text] [PDF]

				J. Narula and V. Dilsizian From better understood pathogenesis to superior molecular imaging, and back... J. Am. Coll. Cardiol. Img., May 1, 2008; 1(3): 406 - 409. [Full Text] [PDF]

				E. D. Abel, S. E. Litwin, and G. Sweeney Cardiac Remodeling in Obesity Physiol Rev, April 1, 2008; 88(2): 389 - 419. [Abstract] [Full Text] [PDF]

				K. M. Eggers, B. Lagerqvist, P. Venge, L. Wallentin, and B. Lindahl Persistent Cardiac Troponin I Elevation in Stabilized Patients After an Episode of Acute Coronary Syndrome Predicts Long-Term Mortality Circulation, October 23, 2007; 116(17): 1907 - 1914. [Abstract] [Full Text] [PDF]

				A. C. Shuros, R. W. Salo, V. G. Florea, J. Pastore, M. A. Kuskowski, Y. Chandrashekhar, and I. S. Anand Ventricular Preexcitation Modulates Strain and Attenuates Cardiac Remodeling in a Swine Model of Myocardial Infarction Circulation, September 4, 2007; 116(10): 1162 - 1169. [Abstract] [Full Text] [PDF]

				S. Merkle, S. Frantz, M. P. Schon, J. Bauersachs, M. Buitrago, R. J.A. Frost, E. M. Schmitteckert, M. J. Lohse, and S. Engelhardt A Role for Caspase-1 in Heart Failure Circ. Res., March 16, 2007; 100(5): 645 - 653. [Abstract] [Full Text] [PDF]

				D. Hilfiker-Kleiner, U. Landmesser, and H. Drexler Molecular Mechanisms in Heart Failure: Focus on Cardiac Hypertrophy, Inflammation, Angiogenesis, and Apoptosis J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A56 - A66. [Abstract] [Full Text] [PDF]

				S. Roy, S. Khanna, D. E. Kuhn, C. Rink, W. T. Williams, J. L. Zweier, and C. K. Sen Transcriptome analysis of the ischemia-reperfused remodeling myocardium: temporal changes in inflammation and extracellular matrix Physiol Genomics, May 16, 2006; 25(3): 364 - 374. [Abstract] [Full Text] [PDF]

				S. Xydas, A. R. Kherani, J. S. Chang, S. Klotz, I. Hay, C. J. Mutrie, G. W. Moss, A. Gu, A. R. Schulman, D. Gao, et al. beta2-Adrenergic Stimulation Attenuates Left Ventricular Remodeling, Decreases Apoptosis, and Improves Calcium Homeostasis in a Rodent Model of Ischemic Cardiomyopathy J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 553 - 561. [Abstract] [Full Text] [PDF]

				T. A. Williams, A. Verhovez, A. Milan, F. Veglio, and P. Mulatero Protective Effect of Spironolactone on Endothelial Cell Apoptosis Endocrinology, May 1, 2006; 147(5): 2496 - 2505. [Abstract] [Full Text] [PDF]

				I. S. Douglas, F. D. del Valle, R. A. Winn, and N. F. Voelkel beta-Catenin in the Fibroproliferative Response to Acute Lung Injury Am. J. Respir. Cell Mol. Biol., March 1, 2006; 34(3): 274 - 285. [Abstract] [Full Text] [PDF]

				L Galiuto, M Lotrionte, F Crea, A Anselmi, G G L Biondi-Zoccai, F De Giorgio, A Baldi, F Baldi, G Possati, M Gaudino, et al. Impaired coronary and myocardial flow in severe aortic stenosis is associated with increased apoptosis: a transthoracic Doppler and myocardial contrast echocardiography study Heart, February 1, 2006; 92(2): 208 - 212. [Abstract] [Full Text] [PDF]

				J. Arredondo, A. I. Chernyavsky, A. Karaouni, and S. A. Grando Novel Mechanisms of Target Cell Death and Survival and of Therapeutic Action of IVIg in Pemphigus Am. J. Pathol., December 1, 2005; 167(6): 1531 - 1544. [Abstract] [Full Text] [PDF]

				A. Abbate, R. Bussani, G. G.L. Biondi-Zoccai, D. Santini, A. Petrolini, F. D. Giorgio, F. Vasaturo, S. Scarpa, A. Severino, G. Liuzzo, et al. Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium Eur. Heart J., October 1, 2005; 26(19): 2039 - 2045. [Abstract] [Full Text] [PDF]

				V. P.M. van Empel, A. T.A. Bertrand, L. Hofstra, H. J. Crijns, P. A. Doevendans, and L. J. De Windt Myocyte apoptosis in heart failure Cardiovasc Res, July 1, 2005; 67(1): 21 - 29. [Abstract] [Full Text] [PDF]

				R. Gottlieb ICE-ing the Heart Circ. Res., May 27, 2005; 96(10): 1036 - 1038. [Full Text] [PDF]

				B. Schreiber Levocarnitine and Dialysis: A Review Nutr Clin Pract, April 1, 2005; 20(2): 218 - 243. [Abstract] [Full Text] [PDF]

				N. Narula, J. Narula, P. J. Zhang, N. Haider, P. N. Raghunath, R. Brittin, J. H. Gorman III, R. C. Gorman, and J. E. Tomaszewski Is the Myofibrillarlytic Myocyte a Forme Fruste Apoptotic Myocyte? Ann. Thorac. Surg., April 1, 2005; 79(4): 1333 - 1337. [Abstract] [Full Text] [PDF]

				S. M. Dallabrida, N. Ismail, J. R. Oberle, B. E. Himes, and M. A. Rupnick Angiopoietin-1 Promotes Cardiac and Skeletal Myocyte Survival Through Integrins Circ. Res., March 4, 2005; 96(4): e8 - e24. [Abstract] [Full Text] [PDF]

				C.-Y. Xiao, M. Chen, Z. Zsengeller, H. Li, L. Kiss, M. Kollai, and C. Szabo Poly(ADP-Ribose) Polymerase Promotes Cardiac Remodeling, Contractile Failure, and Translocation of Apoptosis-Inducing Factor in a Murine Experimental Model of Aortic Banding and Heart Failure J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 891 - 898. [Abstract] [Full Text] [PDF]

				A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, B. H. Greenberg, J. D. Knoke, K. U. Knowlton, W. Y.W. Lew, J. Narula, D. Sahn, et al. Highlights of the year in JACC 2004 J. Am. Coll. Cardiol., January 4, 2005; 45(1): 137 - 153. [Full Text] [PDF]